Summary & Overview
HCPCS P2033: Thymol Turbidity, Blood
HCPCS Level II code P2033 represents the laboratory measurement “thymol turbidity, blood.” As a specialized laboratory assay with limited contemporary clinical use, the code is relevant for billing and historical reporting of biochemical or research-related blood turbidity testing. Nationally, accurate coding ensures proper claims processing and documentation for laboratory services that may be ordered in niche clinical situations or research settings.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise view of what the code denotes, the expected service setting, and the payer landscape covered. The publication outlines common billing considerations, the clinical context for the test, and where to look for payer-specific coverage guidance. It also summarizes typical site-of-service expectations and the role of this assay in laboratory workflows.
This summary is intended for billing managers, laboratory directors, and clinicians who need a clear reference for HCPCS Level II code P2033, including how the code fits into laboratory service lines and the national payer environment. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code P2033 describes thymol turbidity, blood. This service is a laboratory test that measures the turbidity of blood in the presence of thymol reagent, used historically as a nonspecific indicator in certain clinical and research contexts.
-
Service type: Laboratory test
-
Typical site of service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A 58-year-old outpatient presents for evaluation of chronic liver disease and abnormal routine chemistry results, including jaundice and mild coagulopathy. The clinician orders a serum thymol turbidity test (P2033) as part of an older panel used to assess globulin and liver synthetic function when more specific tests are unavailable or as a historical local laboratory practice. The specimen is collected via standard venipuncture in the outpatient phlebotomy area. The sample is sent to the clinical laboratory; the laboratory technologist performs the thymol turbidity assay manually or with automated turbidimetry to measure serum protein precipitation (turbidity) in an alkaline thymol solution. Results are reported in the electronic health record and interpreted by the ordering provider alongside liver function tests (e.g., bilirubin, albumin, prothrombin time) to support assessment of hepatic synthetic impairment or hypergammaglobulinemia. Typical sites of service include hospital outpatient laboratories, independent clinical laboratories, and ambulatory clinic labs. Common patient scenarios include evaluation for chronic hepatitis, cirrhosis, suspected multiple myeloma or other dysproteinemias, and follow-up of abnormal liver panel findings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician interpretation or professional component of the laboratory service is billed separately from the technical component. |